Abstract
The matrix metalloproteinases (MMPs) have been implicated as contributing factors in the pathogenesis of injury and inflammation of the central nervous system including diseases such as Alzheimer (Gottschall & Yu, 1995), Multiple Sclerosis (MS) and its animal model, experimental autoimmune encephalitis (EAE) (Gijbels et al., 1992; Norga et al., 1995; Rosenberg et al., 1996). MMP activity has been associated with degradation of the extracellular matrix (ECM), activation of leukocytes, their extravasation and tissue infiltration, breakdown of the blood brain barrier (BBB) as well as nerve demyelination (Romanic & Madri, 1994). The process of regeneration and glial-scar formation also depends upon modulation of the ECM by MMPs, thus enabling glial cells to migrate to damaged areas of the brain (McKeon et al., 1995).
| Original language | American English |
|---|---|
| Title of host publication | Progress in Alzheimer’s and Parkinson’s Diseases |
| Editors | Abraham Fisher, Israel Hanin, Mitsuo Yoshida |
| Place of Publication | Boston, MA |
| Publisher | Springer US; Imprint: Springer |
| Pages | 149-157 |
| Number of pages | 9 |
| ISBN (Print) | 978-1-4615-5337-3 |
| DOIs | |
| State | Published - 1998 |
Fingerprint
Dive into the research topics of 'Matrix-Metalloproteinases (MMPS) in Astroglial Cells'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver